At the end of today’s trading session, the market valuation of Dilip Shanghvi-led Sun Pharmaceutical stood at Rs 2,15,332.69 crore — which was more than Rs 4,200 crore higher than that of SBI’s Rs 2,11,130.87 crore.
Earlier this month, Shanghvi surpassed Mukesh Ambani as the richest Indian with a networth of USD 21.5 billion. Ambani-led RIL currently ranks as the country’s second most valued company after state-run ONGC.
Shares of Sun Pharma ended the day with a gain of 1.12 per cent at Rs 1,039.70, while those of SBI also rose by 0.41 per cent to reach Rs 282.80 on the BSE.
With this, Sun Pharma now stands at eight position in the list of the most valued companies, followed by SBI at ninth place.
Market capitalisation of a listed company corresponds to the cumulative market price of all its shares. This figure changes daily with change in stock price.